Stock listing

NASDAQ:ITMN InterMune Inc Stock

Follow InterMune Inc into a list and get an email when it puts out news.

Last close · NASDAQ:ITMN

$73.89 USD

Close on Sep 26, 2014 · No longer trades

Mar 24, 2000 to last close +195.6% · monthly closes, Mar 24, 2000 – Sep 26, 2014
Lowest – highest close
$7.24 – $73.91 USDSince Mar 24, 2000 · lowest Aug 20, 2012 · highest Sep 25, 2014

Delisted NASDAQ:ITMN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:ITMN
Asset type
Stock
Exchange
NASDAQ
Currency
USD

InterMune Inc on 6ix

Decks
4 decks · latest Jun 4, 2014

Decks

DeckKindSlidesDate
Investor Presentation (June 2014)Investor deck40 slidesJun 4, 2014
Technical Presentation (February 2014)Technical25 slidesFeb 25, 2014
J.P. Morgan 2014 Healthcare ConferenceConference29 slidesJan 13, 2014
J.P. Morgan 31st Annual Healthcare Conference 2013Conference27 slidesJan 7, 2013

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
William R Ringo
Other companies: Assembly Biosciences, Inc. (Director · Since at least Jul 10, 2014); Sensei Biotherapeutics, Inc. (Director · Mar 8, 2022 – May 21, 2025 · Past); Five Prime Therapeutics Inc (Director · Oct 1, 2014 – Apr 5, 2021 · Past); Immune Design Corp (Director · Jul 23, 2014 – Apr 2, 2019 · Past); Onyx Pharmaceuticals Inc (Director · Feb 3, 2011 – Oct 1, 2013 · Past); Sangamo Therapeutics, Inc. (Director · Apr 16, 2010 – Sep 20, 2017 · Past); Pfizer, Inc. (Senior Vice President · Apr 1, 2008 – Mar 31, 2010 · Past); Allos Therapeutics Inc (Director · Jan 5, 2007 – Jun 19, 2007 · Past); Inspire Pharmaceuticals Inc (Director · Jun 13, 2006 – Jun 8, 2007 · Past); Abgenix Inc (CEO and President, Director · Apr 1, 2006 – Apr 1, 2006 · Past)
Director · Feb 23, 2006 – May 15, 2007 · Past
Daniel G. Welch
Other companies: Prothena Corporation plc (Chair of the Board · Since at least Feb 21, 2024); Structure Therapeutics, Inc. (Director · Since at least Feb 2, 2023); Ultragenyx Pharmaceutical Inc. (Director · Since at least Apr 8, 2015); Nuvation Bio Inc. (Director · Feb 10, 2021 – May 24, 2024 · Past); AveXis Inc (Director · Feb 10, 2016 – May 15, 2018 · Past); Intercept Pharmaceuticals Inc (Director · Nov 24, 2015 – May 28, 2020 · Past); Corium International Inc (Director · Apr 2, 2014 – Apr 2, 2014 · Past); Hyperion Therapeutics Inc (Director · Aug 23, 2012 – May 7, 2015 · Past); Seagen Inc (Director · Jun 13, 2007 – Dec 14, 2023 · Past)
Chairman, CEO and President, Director · Mar 15, 2006 – Sep 29, 2014 · Past
Jonathan Leff
Other companies: Larimar Therapeutics, Inc. (Director · Since at least May 28, 2020); BiomX Inc. (Director · Mar 15, 2024 – Apr 14, 2025 · Past); ARS Pharmaceuticals, Inc. (Director · Nov 8, 2022 – Nov 8, 2022 · Past); Protara Therapeutics, Inc. (Director · Aug 2, 2017 – Jun 8, 2018 · Past); AveXis Inc (Director · Feb 10, 2016 – Feb 10, 2016 · Past); Alpine Immune Sciences Inc (Director · Jun 16, 2015 – Sep 11, 2015 · Past)
EVP, Research & Development · Feb 27, 2012 – Sep 29, 2014 · Past
Lars G. Ekman
Other companies: Prothena Corporation plc (Chair Emeritus · Since at least Dec 20, 2012); Ultragenyx Pharmaceutical Inc. (Director · Mar 17, 2016 – Jun 24, 2022 · Past); Spark Therapeutics Inc (Director · Jan 29, 2015 – Dec 17, 2019 · Past); Ocera Therapeutics Inc (Director · Jul 15, 2013 – Jun 11, 2014 · Past); Amarin Corporation plc (Director · Dec 30, 2010 – Jun 27, 2022 · Past); Aryx Therapeutics Inc (Director · Apr 30, 2010 – Apr 30, 2010 · Past)
Director · May 10, 2010 – Sep 29, 2014 · Past
Paul D ArataEVP, Human Resources & Admin · Jul 16, 2012 – Sep 29, 2014 · Past
Williamson Z Bradford IIISVP-Clinical Science · Jan 16, 2006 – May 11, 2012 · Past

Open People

Log in to ask 6ix AI your own questions about InterMune Inc.